A concurrent resolution respecting Congressional oversight and agency studies of the appropriateness of continued use of the pertussis vaccine.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Requires the appropriate congressional committees to begin oversight hearings on: (1) the safety of the use of the pertussis vaccine; (2) the activities of the Food and Drug Administration and the Centers for Disease Control respecting the use of the vaccine and the incidence of its side effects; and (3) the need for additional legislation respecting regulation of such vaccine.
Expresses the sense of Congress that the Food and Drug Administration should begin an epidemiological study, and other appropriate studies, to determine whether or not it is consistent with public health to require or to promote the continued use of pertussis vaccine.
Referred to Subcommittee on Health and the Environment.
Cite this page
U.S. Congress. (2026). H. Con. Res. 313: A concurrent resolution respecting Congressional oversight and agency studies of the appropriateness of continued use of the pertussis vaccine.. 97th Congress. Open America. https://openamerica.io/bill/97-HCONRES-313/
"H. Con. Res. 313: A concurrent resolution respecting Congressional oversight and agency studies of the appropriateness of continued use of the pertussis vaccine.." 97th Congress, 2026, Open America, https://openamerica.io/bill/97-HCONRES-313/.
H. Con. Res. 313, 97th Cong. (2026), https://openamerica.io/bill/97-HCONRES-313/.
[H. Con. Res. 313: A concurrent resolution respecting Congressional oversight and agency studies of the appropriateness of continued use of the pertussis vaccine.](https://openamerica.io/bill/97-HCONRES-313/)